InvestorsHub Logo
Followers 11
Posts 746
Boards Moderated 0
Alias Born 09/21/2017

Re: None

Thursday, 12/21/2017 4:53:43 AM

Thursday, December 21, 2017 4:53:43 AM

Post# of 106834
This portion worth repeating:

“U.S. Stem Cell and its affiliated entities did not administer the treatment to the patient. The procedure was performed by an outside practitioner, who is among the hundreds of trained doctors worldwide who utilize U.S. Stem Cell, Inc. technology. U.S. Stem Cell does not currently treat eye patients, and for nearly 20 years, clinics have safely conducted thousands of stem cell procedures utilizing our protocol. We remain committed to the development of effective cell technologies to treat patients with a variety of diseases and injuries.

U.S. Stem Cell, Inc. is an emerging leader in the regenerative medicine / cellular therapy industry specializing in physician training and certification and stem cell products including its lead product Adipocell TM , as well as veterinary stem cell training and stem cell banking and creation and management of stem cell clinics. To management’s knowledge, USRM has completed more clinical treatments than any other stem cell company in the world in the past 20 years, and has certified more than 700 physicians and veterinarians in autologous stem cell therapy worldwide”

https://www.prnewswire.com/news-releases/usrm-responds-to-lawsuit-filed-for-discontinued-eye-treatments-300573702.html